HPV vaccine eliminates cervical cancer cases in vaccinated Scottish women, landmark studies show
Summary
Landmark population-based studies from Scotland and the Netherlands provide compelling real-world evidence that HPV vaccines are highly effective at preventing cervical cancer. The Scottish study found zero cases of invasive cervical cancer among women vaccinated at ages 12-13 after 8-12 years of follow-up, while a Dutch national study of over 100,000 women confirmed significant protection from the bivalent HPV vaccine. These findings, more than a decade after vaccination programs began, demonstrate dramatic reductions in cervical cancers and precancers across multiple countries.
Source
Key quotes
· 3 pulledA population-based study of all women born in Scotland between 1 January 1988 and 5 June 1996, linking immunisation, cervical screening and cancer registry data, found no cases of invasive cervical cancer among those vaccinated with the bivalent HPV vaccine (Cervarix) at ages 12-13 after 8-12 years of follow-up.
A national linkage study combining vaccination, pathology, and cancer registry data for 103,059 Dutch women, found that those fully vaccinated with the bivalent HPV vaccine (Cervarix)
More than a decade after the first HPV vaccination programmes rolled out, data from multiple countries reveals a dramatic fall in cervical cancers and precancers, confirming that HPV vaccines are highly effective and extremely safe.
You might also wanna read
Long-term HPV vaccine effectiveness study shows stable protection against targeted virus types in Danish women vaccinated as girls
This study examines the long-term effectiveness of HPV vaccination in Danish women who received the 4-valent HPV vaccine as girls in 2008. T
HPV vaccine linked to zero cervical cancer deaths in young women in England for first time
New data from England shows zero cervical cancer deaths among women aged 20-24 between 2020 and 2024, marking the first time this has been r
Denmark Eliminates Leading Cancer-Causing HPV Strains Following 2008 Vaccine Rollout
Denmark has successfully eliminated infections from the two most dangerous cancer-causing HPV strains (types 16 and 18) following the introd
HPV Vaccine at 20: Proven Cancer Prevention Tool Faces Uptake Challenges
The article marks the 20th anniversary of the FDA's approval of the first HPV vaccine in 2006, highlighting its evolution from a quadrivalen
Personalized mRNA Cancer Vaccine Shows 49% Risk Reduction at 5-Year Follow-up
Moderna and Merck report promising 5-year follow-up results for their personalized mRNA cancer vaccine combined with Keytruda immunotherapy.
arstechnica.com·4mo agoScientists Develop Universal Cancer Vaccine Using mRNA Technology
Scientists have developed a 'universal cancer vaccine' using mRNA technology that can train the immune system to target any type of cancer,
Comments
Sign in to join the conversation.
No comments yet. Be the first.
